FDA Investigator Vivin George

Vivin George has conducted inspections on 35 sites in 3 countries as of 06 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
35
Last Inspection Date:
06 May 2024
Investigator Role:
FDA Investigator
Redica ID:
100000366
Countries of Inspections:
United States of America, India, Thailand
FDA Investigators that have inspected at least one site in common with Vivin George:
Abdellah El Hajjam, Alan P Kurtzberg, Alanna L Mussawwir Bias, Alberto A Viciedo, Alice S Tsao, Alison N Stieg, Amatul H Marium, Anastasia M Shields, Anissa M Vargas, Annet R Rajan, Arduino Frankovic, Arthur G Hurst, Barbara A Gullick, Bijoy Panicker, Brandi L Garbutt, Brandy N Lepage, Brooke K Higgins, Camerson E Moore, Catherine O Lamptey, CDR Ileana Barreto Pettit, Chaltu Nwakijra, Charanjeet Jassal, Charisse K Green, Chiang Syin, PhD, Christie A Garcia, Christie A Soto, Christina K Theodorou, Christos G Tsingelis, Courtney N Long, Craig D Zagata, David A Oluwo, Demitria J Argiropoulos, Demitria J Xiradakis, Deyaa Shaheen, Douglas A Campbell, Douglas G Ng, Dr. Dominick Roselle, Dr. Gopa Biswas, PhD, Dr. Robert C Horan, MD, Dr. Roslyn F Powers, Dr. Yubing Tang, Edmund F Mrak, Jr, Emest F Bizjak, Eric L Dong, BS, Felix Maldonado, Gam S Zamil, George Pyramides, Gregory Price, Gregson A Joseph, Hector Jcolon Torres, Helen B Ricalde, Iram R Hassan, PhD, Jacqueline S Warner, James A Liubicich, James M Mason, James M Simpson, Jay T Wong, Jennifer C Adams, Jennifer L Bridgewater, Jennifer L Huntington, Jennifer Lalama, Jennifer M Menendez, Jessica L Pressley, Joanne E King, Jogy George, Jonah S Ufferfilge, Jonathan G Matrisciano, Jonathan W Chapman, Jose Velez, Joseph W Matthews, Joshua J Silvestri, Juanita P Versace, Juliana M Badalucco, Julianne C Mccullough, Junho Pak, Karen L Kosar, Karishma G Gopaul, Katherine Szestypalow, Kathleen M Jordan, Kayla V Sprague, Kenneth M Gordon, Kenneth Nieves, Kevin A Gonzalez, Ko U Min, Kristina L Conroy, Kwong P Lee, Larry K Hampton, Lata C Mathew, PhD, Laura D Cain, Laura Fontan, MS, Lawrence Harmon, Jr, LCDR Michael H Tollon, Lillian Mcolon Mcknight, Linda F Murphy, Linda Thai, Loretta Nemchik, Lori S Lawless, Marc S Neubauer, Marcellinus D Dordunoo, Marcus A Ray, Margaret M Doherty, Matthew A Spataro, Matthew M Henciak, Maureen A Wentzel, Melissa J Garcia, Melkamu Getie Kebtie, PhD, Michael A Charles, Michael Shanks, MS, Mindy M Chou, Miral B Patel, Misty L Treece, Mizanne E Lewis, Muralidhara B Gavini, PhD, Nadeem I Chaudhry, Nancy M Espinal, Naveen B Kanthamneni, Nebil A Oumer, Neil J Bonzagni, PhD MPH, Nicholas A Violand, Nicholas Z Lu, Nicole E Knowlton, Nikisha M Bolden, Olumide A Akinyemi, Parul M Patel, Patrick C Klotzbuecher, Paul L Bellamy, Paul Mouris, Peter S Diak, Philippa Hillyer, Rachael A Moliver, Rachael O Oyewole, Rachel A Peters, Rachel C Harrington, Raihan A Chowdhury, Rebecca Rodriguez, Richard K Glabach, Robert C Steyert, Robert H Wittorf, Robert J Martin, Rose Xu, Russell J Glapion, Samina S Khan, Sarah E Mcmullen, Satheesh Thomas, Sayyem H Akbar, Scott B Laufenberg, Sharon K Thoma, PharmD, Shirshendu K Deb, PhD, Simone E Pitts, Sony Mathews, Steven M Weinman, Suzanne N Vallez, Syeda N Mahazabin, Tanya R Syffrard, Tara K Carmody, Tara K Normandin, Terry Bridgewater, Thomas E Friel, Tiara Nbrown Crosen, Tonia F Bernard, Toyin B Oladimeji, Uduak M Inokon, Viviana Matta, Walter L Fava, Wanda Y Honeyblue, Xikui Chen (nmi), PhD, Yifan Wang, Yvesna C Blaise, Yvins Dezan, Zhongren Wu

Vivin George's Documents

Publish Date Document Type Title
February, 2020 FDA 483 Applied Consumer Services, Inc. - Form 483, 2020-02-21
October, 2019 FDA 483 AIRGAS USA, LLC - Form 483, 2019-10-18
November, 2022 FDA 483 Port Jervis Laboratories, Inc - Form 483, 2022-11-04
November, 2022 EIR Pharmaceutics International, Inc. - EIR, 2022-11-14
June, 2021 EIR Professional Disposables International, Inc. - EIR, 2021-07-30
February, 2023 FDA 483 HomeoCare Laboratories Inc. - Form 483, 2023-02-21
March, 2022 FDA 483 American Cleaning Solutions - Form 483, 2022-03-28
November, 2022 EIR Port Jervis Laboratories, Inc - EIR, 2022-11-04
August, 2021 FDA 483 Advanced Pharmaceutical Technology, Inc. - Form 483, 2021-08-23
June, 2023 FDA 483 Amneal Pharmaceuticals of New York, LLC - Form 483, 2023-06-07
September, 2019 FDA 483 DAP Pharmaceuticals, LLC - Form 483, 2019-09-11
February, 2022 FDA 483 BIOCON GENERICS INC - Form 483, 2022-02-02
December, 2021 FDA 483 ScieGen Pharmaceuticals INC - Form 483, 2021-12-20
April, 2024 FDA 483 Optisource International Inc. - Form 483, 2024-04-04
March, 2020 FDA 483 CORERX, INC. - Form 483, 2020-03-06
March, 2020 EIR CORERX, INC. - EIR, 2020-03-06
November, 2022 FDA 483 Pharmaceutics International, Inc. - Form 483, 2022-11-14
October, 2022 FDA 483 MANA PRODUCTS, INC. - Form 483, 2022-10-17
October, 2020 FDA 483 Syntec Pharma Corp. - Form 483, 2020-10-28
June, 2021 FDA 483 Response Professional Disposables International, Inc. - Form 483R, 2021-06-23
November, 2022 FDA 483 Response Port Jervis Laboratories, Inc - Form 483R, 2022-11-23
November, 2022 FDA 483 Pharmaceutics International, Inc. - Form 483, 2022-11-14
December, 2022 FDA 483 Keystone Industries - Form 483, 2022-12-21
December, 2023 FDA 483 Phoenix Wipes Inc - Form 483, 2023-12-19
January, 2020 FDA 483 Atlantic Biologicals - Form 483, 2020-01-14
March, 2023 FDA 483 Xylo Chem Industries - Form 483, 2023-03-31
March, 2020 FDA 483 Response CORERX, INC. - Form 483R, 2020-03-27
November, 2022 EIR Pharmaceutics International, Inc. - EIR, 2022-11-14
June, 2021 FDA 483 Professional Disposables International, Inc. - Form 483, 2021-06-23
April, 2022 FDA 483 Positive Promotions Inc. - Form 483, 2022-04-25
May, 2024 FDA 483 Clean Solutions LLC - Form 483, 2024-05-10
April, 2023 FDA 483 R.L.Fine Chem Private Limited - Form 483, 2023-04-14
March, 2024 FDA 483 Kaylaan LLC - Form 483, 2024-03-01
July, 2024 FDA 483 AIRGAS USA, LLC - Form 483, 2024-07-31

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more